Donggong Daxin Biotechnology

Daxin Biotech is a Taiwan-based biotechnology company specializing in the development and large-scale manufacture of active pharmaceutical ingredients (APIs) through advanced fermentation technology. A subsidiary of the Formosa Plastics Group, the company is a global leader in the production of statins, including Lovastatin, Simvastatin, and Pravastatin, which are used to treat hypercholesterolemia. Beyond its core statin portfolio, Daxin Biotech provides contract manufacturing services (CMO) for various microbial-derived products and specialty chemicals. The company operates state-of-the-art fermentation and purification facilities that comply with international Good Manufacturing Practice (GMP) standards. Its business model focuses on high-quality API supply to pharmaceutical companies worldwide, leveraging the industrial scale and vertical integration of its parent conglomerate.